Literature DB >> 672709

Cancer as a systemic disease.

G Zajicek.   

Abstract

Theories on the nature of cancer may be classified into two categories. One regards cancer strictly as a local phenomenon while the second looks at cancer as a local manifestation of a systemic process or disease. Although the first dominates current medical thought, the theories of immunological surveillance and of protovirus-oncogene implicitly assume cancer to represent a local manifestation of a systemic process or disease. This is supported also by epidemiological data forwarded in the present paper. In order to clarify the exact meaning of a systemic disease, cancer and its manifestation are compared with arteriosclerosis and its sequelae. Arteriosclerosis could be regarded as a prototype of a systemic disease. It presents itself clinically solely by its local manifestations, like myocardial infarction or stroke. These local manifestations may be followed by secondary systemic sequelae like congestive heart failure. In the same context, it is proposed to regard cancer as one systemic disease which presents itself clinically by local phenomena like carcinoma, lymphoma and sarcoma. These local manifestations may lead further to secondary systemic sequelae like metastasis.

Entities:  

Mesh:

Year:  1978        PMID: 672709     DOI: 10.1016/0306-9877(78)90002-6

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

Review 1.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  The independent effect of cancer on outcomes: a potential limitation of surgical risk prediction.

Authors:  Ira L Leeds; Joseph K Canner; Jonathan E Efron; Nita Ahuja; Elliott R Haut; Elizabeth C Wick; Fabian M Johnston
Journal:  J Surg Res       Date:  2017-09-18       Impact factor: 2.192

Review 3.  Mechanisms of resistance to chemotherapy in non-small cell lung cancer.

Authors:  Hye-Young Min; Ho-Young Lee
Journal:  Arch Pharm Res       Date:  2021-02-19       Impact factor: 4.946

Review 4.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

5.  Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer.

Authors:  Nafiseh Pakravan; Ardeshir Abbasi; Zuhair Mohammad Hassan
Journal:  Oxid Med Cell Longev       Date:  2021-05-28       Impact factor: 6.543

6.  Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.

Authors:  Wen Wen Xu; Bin Li; Xin Yuan Guan; Sookja K Chung; Yang Wang; Yim Ling Yip; Simon Y K Law; Kin Tak Chan; Nikki P Y Lee; Kwok Wah Chan; Li Yan Xu; En Min Li; Sai Wah Tsao; Qing-Yu He; Annie L M Cheung
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

Review 7.  Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.

Authors:  Ping-Pin Zheng; Jin Li; Johan M Kros
Journal:  Med Res Rev       Date:  2017-09-01       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.